These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 18373021

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Developing a phone-based measure of impairment after acute oral ∆9-tetrahydrocannabinol.
    Pabon E, de Wit H.
    J Psychopharmacol; 2019 Sep; 33(9):1160-1169. PubMed ID: 31407943
    [Abstract] [Full Text] [Related]

  • 30. Effects of cannabis use status on cognitive function, in males with schizophrenia.
    Rabin RA, Zakzanis KK, Daskalakis ZJ, George TP.
    Psychiatry Res; 2013 Apr 30; 206(2-3):158-65. PubMed ID: 23246245
    [Abstract] [Full Text] [Related]

  • 31. The residual cognitive effects of heavy marijuana use in college students.
    Pope HG, Yurgelun-Todd D.
    JAMA; 1996 Feb 21; 275(7):521-7. PubMed ID: 8606472
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Profile of executive deficits in cocaine and heroin polysubstance users: common and differential effects on separate executive components.
    Verdejo-García A, Pérez-García M.
    Psychopharmacology (Berl); 2007 Mar 21; 190(4):517-30. PubMed ID: 17136401
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Differential impairments of selective attention due to frequency and duration of cannabis use.
    Solowij N, Michie PT, Fox AM.
    Biol Psychiatry; 1995 May 15; 37(10):731-9. PubMed ID: 7640328
    [Abstract] [Full Text] [Related]

  • 36. Effects of regular cannabis use on neurocognition, brain structure, and function: a systematic review of findings in adults.
    Nader DA, Sanchez ZM.
    Am J Drug Alcohol Abuse; 2018 May 15; 44(1):4-18. PubMed ID: 28498718
    [Abstract] [Full Text] [Related]

  • 37. The effects of synthetic cannabinoids on executive function.
    Cohen K, Kapitány-Fövény M, Mama Y, Arieli M, Rosca P, Demetrovics Z, Weinstein A.
    Psychopharmacology (Berl); 2017 Apr 15; 234(7):1121-1134. PubMed ID: 28160034
    [Abstract] [Full Text] [Related]

  • 38. Cognitive measures in long-term cannabis users.
    Pope HG, Gruber AJ, Hudson JI, Huestis MA, Yurgelun-Todd D.
    J Clin Pharmacol; 2002 Nov 15; 42(S1):41S-47S. PubMed ID: 12412835
    [Abstract] [Full Text] [Related]

  • 39. MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress.
    Parrott AC.
    J Psychopharmacol; 2006 Mar 15; 20(2):147-63. PubMed ID: 16510474
    [Abstract] [Full Text] [Related]

  • 40. Cannabis and tolerance: acute drug impairment as a function of cannabis use history.
    Ramaekers JG, van Wel JH, Spronk DB, Toennes SW, Kuypers KP, Theunissen EL, Verkes RJ.
    Sci Rep; 2016 May 26; 6():26843. PubMed ID: 27225696
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.